Health Condition 1: null- localised periodontitis
Conditions
Interventions
Intervention1: Acacia Arabica: Phyto pharmaceutical drug
used twice daily as local application in the affected area
about pea size gel for one tooth area
for 3 months.
Control Intervention1: placebo: A placebo gel.
used twice daily as local application in the affected area
for 3 months.
Sponsors
Dr Rameshwari Singhal
Charak pharmaceuticals
Eligibility
Inclusion criteria
Inclusion criteria: • Subjects of age 18 years or older of either gender in good general health condition • Subjects with mild to moderate Periodontitis (pocket depth 4-6mm) • Patients willing to sign Informed Consent Form.
Exclusion criteria
Exclusion criteria: •History of tobacco chewing / smoking •Any known clinically significant hematological, endocrine disorders, hepatic or renal diseases, cardiovascular, cerebrovascular or psychiatric diseases likely to alter the treatment outcome, or could compromise the subjectâ??s participation in the trial •Subjects who used medication that would interfere with the efficacy and safety objectives of the trial or who were not stabilized on any concomitant medication (continuous use) during at least three months prior to randomization. •Patients who participate in other study protocols
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary efficacy outcomes: â?¢ Gingival index- Loe and Silness â?¢ Bleeding Index- Ainamo and Bay â?¢ Plaque Index- Silness and Loe. â?¢ PPD (Probing Pocket Depth) using Florida probe â?¢ CAL (clinical attachment level) using Florida probe. Timepoint: at baseline and 3 months after drug delivery. | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Modified OHRQL instrumentTimepoint: Baseline & 3 months | — |
Countries
India
Contacts
Public ContactDr Rameshwari Singhal
Chhattarpati Shahuji Maharaj medical University
Outcome results
None listed